Recursion (RXRX) acquires full rights to oral HPP treatment REV102
Go back to Recursion (RXRX) acquires full rights to oral HPP treatment REV102| (NASDAQ: RLYB) | Delayed: 16.38 -0.23 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.61 | 52 Week High | $ | |||
| Open | $16.81 | 52 Week Low | $ | |||
| Day High | $16.81 | P/E | N/A | |||
| Day Low | $16.34 | EPS | $ | |||
| Volume | 8,781 | |||||
| (NASDAQ: RXRX) | Delayed: 3.35 +0.06 (1.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.29 | 52 Week High | $ | |||
| Open | $3.32 | 52 Week Low | $ | |||
| Day High | $3.42 | P/E | N/A | |||
| Day Low | $3.27 | EPS | $ | |||
| Volume | 11,007,616 | |||||

